Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/27043
Title: Assessing and addressing cognitive impairment in bipolar disorder: the International Society for Bipolar Disorders Targeting Cognition Task Force recommendations for clinicians
Authors: MISKOWIAK, K. W.BURDICK, K. E.MARTINEZ-ARAN, A.BONNIN, C. M.BOWIE, C. R.CARVALHO, A. F.GALLAGHER, P.LAFER, B.LOPEZ-JARAMILLO, C.SUMIYOSHI, T.MCINTYRE, R. S.SCHAFFER, A.PORTER, R. J.PURDON, S.TORRES, I. J.YATHAM, L. N.YOUNG, A. H.KESSING, L. V.VIETA, E.
Citation: BIPOLAR DISORDERS, v.20, n.3, p.184-194, 2018
Abstract: ObjectivesCognition is a new treatment target to aid functional recovery and enhance quality of life for patients with bipolar disorder. The International Society for Bipolar Disorders (ISBD) Targeting Cognition Task Force aimed to develop consensus-based clinical recommendations on whether, when and how to assess and address cognitive impairment. MethodsThe task force, consisting of 19 international experts from nine countries, discussed the challenges and recommendations in a face-to-face meeting, telephone conference call and email exchanges. Consensus-based recommendations were achieved through these exchanges with no need for formal consensus methods. ResultsThe identified questions were: (I) Should cognitive screening assessments be routinely conducted in clinical settings? (II) What are the most feasible screening tools? (III) What are the implications if cognitive impairment is detected? (IV) What are the treatment perspectives? Key recommendations are that clinicians: (I) formally screen cognition in partially or fully remitted patients whenever possible, (II) use brief, easy-to-administer tools such as the Screen for Cognitive Impairment in Psychiatry and Cognitive Complaints in Bipolar Disorder Rating Assessment, and (III) evaluate the impact of medication and comorbidity, refer patients for comprehensive neuropsychological evaluation when clinically indicated, and encourage patients to build cognitive reserve. Regarding question (IV), there is limited evidence for current evidence-based treatments but intense research efforts are underway to identify new pharmacological and/or psychological cognition treatments. ConclusionsThis task force paper provides the first consensus-based recommendations for clinicians on whether, when, and how to assess and address cognition, which may aid patients' functional recovery and improve their quality of life.
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MPS
Departamento de Psiquiatria - FM/MPS

Artigos e Materiais de Revistas Científicas - LIM/21
LIM/21 - Laboratório de Neuroimagem em Psiquiatria


Files in This Item:
File Description SizeFormat 
art_MISKOWIAK_Assessing_and_addressing_cognitive_impairment_in_bipolar_disorder_2018.PDF
  Restricted Access
publishedVersion (English)484.66 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.